Technical

Delfi Diagnostics raises $225M to develop lung cancer detection technology

Dr. Victor Velculescu, CEO and founder of Delfi Diagnostics. ️ Add Technical.ly to Google Baltimore life sciences company Delfi Diagnostics is $225 million closer to bringing its blood test for early ...
The Daily Record (Maryland)

2025 Best Startup Businesses in Maryland: DELFI Diagnostics

DELFI Diagnostics represents a revolutionary approach to early cancer detection through advanced machine learning and fragmentomics technology. Unlike traditional liquid biopsy methods that search for ...
FierceBiotech

Delfi Diagnostics scoops up $225M from Lilly, Illumina and more for its cancer blood tests

It didn’t take Delfi Diagnostics long after its 2019 founding to hit the coveted nine-digit funding mark: It reached that milestone in early 2021 with the close of its $100 million series A. Less than ...
TMCnet

DELFI Diagnostics Appoints Charles Newton to Board of Directors

"DELFI is tackling one of the most important unmet needs in oncology, and the combination of a differentiated fragmentomics platform, an integrated AI approach, a clear path to FDA approval and broad ...
Business Insider

Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio of Liquid Biopsy Tests

DFJ Growth's Justin Kao Joins Delfi Board of Directors BALTIMORE and PALO ALTO, Calif., July 18, 2022 /PRNewswire/ -- Delfi Diagnostics, Inc., a pioneering developer of a new class of high-performance ...
The Business Journals

Delfi Diagnostics' tech shows early success in detecting 90% of lung cancer cases

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. A pair of studies by Baltimore's Delfi Diagnostics showed ...
Technical

Delfi Diagnostics raises $100M for affordable blood tests to detect cancer early

The Remington-based startup was founded by Johns Hopkins oncology professor Dr. Victor Velculescu, who also cofounded Canton’s Personal Genome Diagnostics. Inside FastForward 1812, an East ...
FierceBiotech

Delfi Diagnostics raises $100M for a new approach to screening blood for cancer

A new method of screening the blood for the telltale signs of tumors promises to offer more chances for a successful result, and Delfi Diagnostics has raised $100 million to help make the cancer test ...
Morningstar

DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference

PALO ALTO, Calif., Jan. 8, 2026 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection, today ...
Nasdaq

DELFI Diagnostics Study on Cancer Treatment Monitoring Using Fragmentomes Featured in Nature Communications

Provider of Accessible Blood-Based Tests for Cancer Detection Highlights Results of Clinical Trial in Preeminent Peer-Reviewed Publication The company currently has an active pipeline of biotech and ...
Yahoo Finance

DELFI Diagnostics to Participate in J.P. Morgan Healthcare Conference

BALTIMORE and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of accessible blood-based, liquid biopsy tests that deliver a new way to enhance early cancer detection ...